Byrne Asset Management LLC Humacyte, Inc. Transaction History
Byrne Asset Management LLC
- $126 Million
- Q2 2025
A detailed history of Byrne Asset Management LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Byrne Asset Management LLC holds 5,000 shares of HUMA stock, worth $9,000. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,000
Previous 3,000
66.67%
Holding current value
$9,000
Previous $5,000
100.0%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HUMA
# of Institutions
182Shares Held
62MCall Options Held
1.21MPut Options Held
877K-
Black Rock Inc. New York, NY7.14MShares$12.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$12.6 Million0.0% of portfolio
-
State Street Corp Boston, MA4.27MShares$7.68 Million0.0% of portfolio
-
Heights Capital Management, Inc San Francisco, CA4.03MShares$7.25 Million3.22% of portfolio
-
Woodline Partners LP San Francisco, CA3.95MShares$7.11 Million0.05% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $185M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...